Top Tweets for #VJSounds

almost 2 years ago

NEW #VJSounds Gene therapy success in diseases like SMA has paved the way for similar approaches in #ALS, with several groundbreaking trials in recent years In this podcast, Prof. Shaw shares insights into ALS gene therapy & explains the challenges 👉https://t.co/c2lyKGLEWg

0

2

0

1

305

over 2 years ago

🆕🧠 Check out the latest episode of the #VJSounds podcast! Breaking the Cycle: Debating Management Approaches in Medication Overuse Headache With #Headache experts Sait Ashina, Morris Levin, Alan Rapoport, & Licia Grazzi: 👉 https://t.co/kk2ucyFAL4

0

1

0

1

384

VJDementia

@VJDementia

about 3 years ago

Wanting to learn more about the role of #microglia in #Alzheimers?🔬 Tune into our latest #VJSounds podcast episode: https://t.co/VbCQSlz7X3 Listen now or save to listen on the go with Spotify, Apple or Podbean! #Neurology #NeuroTwitter #Dementia

0

2

1

574

VJDementia

@VJDementia

over 3 years ago

New episode from #VJSounds: Expert perspectives on lecanemab Lars Lannfelt, Alvaro Pascual-Leone, & Nicolas Villain discuss the unique properties of #lecanemab, safety & efficacy findings, & how the field should move forward in anti-amyloid & beyond ➡️https://t.co/jl6NZHtx2G

0

2

1

0

932

over 3 years ago

The latest from #VJSounds: New research demonstrates that activity-dependent myelin changes driven by absence seizures can contribute to epilepsy progression 🚩🚩 Listen here: https://t.co/xksaETJEFy #Epilepsy #NeuroTwitter #Neurology

0

1

2

0

473

over 3 years ago

New from #VJSounds: The emergence of psychedelic-assisted therapies Our guests discuss new research into psychedelic-assisted therapies & how views surrounding psychedelics within the medical field are evolving Listen now: https://t.co/6zfmQUVCDc #Neurology #NeuroTwitter

0

1

0

478

over 3 years ago

How do environmental risk factors interact with genetics in MS? How can genetics impact #MS progression? Does the microbiome associate with disease risk/severity? Sergio Baranzini (@UCSF) addresses these questions & more in our latest #VJSounds episode: https://t.co/0fbhQTPFh8

0

2

0

over 3 years ago

Exclusively on #VJSounds… trial updates from #Huntingtonsdisease experts! In our new podcast, gain unique insights on current research looking at SAGE-718, pridopidine, PTC518, & ANX005 Discover the latest: ▶️https://t.co/jtPeTfn3Ol #MovementDisorders #NeuroTwitter #Neurology

0

2

0

almost 4 years ago

Are you up to date with the #VJSounds podcast? Tune in to some of our latest episodes: Broadening the use of thrombectomy in #stroke: https://t.co/fco6yLfV50 Gepants for acute & preventive #migraine treatment: https://t.co/eZEH65JCUd #Neurology #NeuroTwitter

0

2

0

VJ Oncology

@VJOncology

over 4 years ago

Want to learn something new this year?🗓️ Why not check out our #VJSounds podcasts?! We've got content from across the field of #Oncology so there's something for everyone! Listen here: 🎧https://t.co/PQEX2NH2dF #SKCsm #GUsm #GIsm #LCsm #PCsm #BCsm "

VJOncology's tweet photo. Want to learn something new this year?🗓️

Why not check out our #VJSounds podcasts?!

We've got content from across the field of #Oncology so there's something for everyone!

Listen here: 🎧https://t.co/PQEX2NH2dF

#SKCsm #GUsm #GIsm #LCsm #PCsm #BCsm " https://t.co/4sy4ZdPnn5

0

3

1

0

over 4 years ago

🎧 Catch up on key updates from the #COSTEM21 meeting with #VJSounds podcasts! 🔊 Maintenance therapies for FLT3+ AML 👉 https://t.co/BZBCNCeTt5 🔊 The role of alloHSCT in ALL 👉 https://t.co/I6B93i6IOB @VJHemOnc #AMLsm #ALLsm #LEUsm #Leukemia #BMTsm #ImmunoOnc #HemOnc

0

3

2

0

almost 5 years ago

#VJSounds | IACH 2021: CAR-T therapy in clinical practice 👩‍⚕️👨‍⚕️ Hear from Arnon Nagler, Anna Sureda, Christian Chabannon and Arnon Kater as they discuss updates in CAR-T therapy from #IACH2021! 🎧 Listen: https://t.co/XP6Sv2N0fG @VJHemOnc #CART #HemOnc #ImmunoOnc #LYMsm #LEUsm

0

5

2

1

0

almost 5 years ago

#VJSounds | Unmet needs and recent updates in the field of chronic myeloid leukemia with Joaquin Martinez-Lopez 👨‍⚕️💭 🎧 Listen here: https://t.co/2Npz0mSgMh @VJHemOnc #LEUsm #Leukemia #CMLsm

0

2

0

almost 5 years ago

#VJSounds | IACH 2021: CAR-T therapy in clinical practice 👩‍⚕️👨‍⚕️ Hear from Arnon Nagler, Anna Sureda, Christian Chabannon and Arnon Kater as they discuss updates in CAR-T therapy from #IACH2021! 🎧 Listen: https://t.co/m5OsOVoDab @VJHemOnc #CART #HemOnc #ImmunoOnc #LYMsm #LEUsm

0

5

2

1

0

almost 5 years ago

#VJSounds | Can we give patients with #MultipleMyeloma treatment-free intervals? Hear the opinions of Philip McCarthy (@PLMcCarthyMD) and Luciano Costa (@End_myeloma) in our latest podcast! 👨‍⚕️👨‍⚕️ 🎧 Listen here: https://t.co/noSKmHMLIt @VJHemOnc #IMW2021 #MMsm #Myeloma

0

3

0

almost 5 years ago

#VJSounds | CAR-T versus bispecific antibodies: replacing ASCT in #Myeloma 🎧 Listen to our latest podcast here: https://t.co/DbMrPMwYtG w/ Hermann Einsele (@H_Einsele) and Parameswaran Hari 👨‍⚕️ @VJHemOnc #MMsm #MultipleMyeloma #HemOnc #ImmunoOncology

0

1

0

almost 5 years ago

Don't miss our #VJSounds podcast on the latest updates on novel agents for AML 📣 Including updates on sabatolimab, glasdegib and olutasidenib for AML 👩‍⚕️👨‍⚕️💉 🎧 Listen now: https://t.co/8YFhpd48hG @VJHemOnc #AMLsm #LEUsm #Leukemia #EHA2021

0

2

1

0

almost 5 years ago

#VJSounds: #TexasMPNWorkshop2021: JAK inhibitors for MPNs Hear from the experts as they discuss key trials and data on JAK inhibitors! 👨‍⚕️👩‍⚕️💉 🎧 Listen here: https://t.co/OGL7PsXOG1 @VJHemOnc #MyeloproliferativeNeoplasms #Myelofibrosis #MPNsm #HemOnc

0

3

0